Menu
+
+
+
+
+
+
The university granted Bio-Matrix's Regen BioPharma Inc. subsidiary an exclusive, six-month option to license exclusive, worldwide rights to U.S. Patent No. 6,821,513 covering methods of stimulating blood...
BioCentury employs a fully integrated multimedia platform — including publications, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
